The Role of Resective Surgery in the Treatment of the Carcinoid Syndrome

References

• Lubarch O. Über den primaren Krebs des Ileum nebst Bemerkungen über des gleichzeitige Vorkommen von Krebs und Tuberculose. Virchows Arch [Pathol Anat] 1888; 111: 281–317
   Google Scholar
• Wilson H, Cheek R C, Sherman R T, Storer E H. Carcinoid tumors. Curr Probl Surg 1970; 2–51, (Nov)
   Google Scholar
• Gosset A, Masson P. Tumeurs endocrines de l'appendice. Presse Med 1914; 22: 237–40
   Google Scholar
• Cassidy M. Abdominal carcinomatosis associated with vasomotor disturbances. Proc R Soc Med 1934; 27: 220–1
   PubMedGoogle Scholar
• Lembeck F. 5-Hydroxytryptamine in a carcinoid tumour [letter]. Nature 1953; 172: 910–1
   Web of Science ®Google Scholar
• Page I H, Corcoran A C, Udenfriend S, Szoedsma A, Weissbach H. Argentafinnoma as endocrine tumour [letter]. Lancet 1955; 1: 198–9
   Web of Science ®Google Scholar
• Oberndorfer S. Über die ‘kleinen Dunndarmcarcinome’. Verh Dtsch Ges Pathol 1907; 11: 113–6
   Google Scholar
• Williams E D, Sandler M. The classification of carcinoid tumours. Lancet 1963; 1: 238–9
   PubMed Web of Science ®Google Scholar
• Feldman J M. Carcinoid tumors and syndromes. Semin Oncol 1987; 14: 237–46
   PubMed Web of Science ®Google Scholar
• Maton P N, Hodgson H JF. Carcinoid tumours and the carcinoid syndrome. Textbook of gastroenterology, I AD Bouchier, R N Allan, H JF Hodgson, M RB Keighley. Bailliere Tindall, Eastbourne 1984; 620–34
   Google Scholar
• Godwin D J. Carcinoid tumours: an analysis of 2837 cases. Cancer 1975; 36: 560–9
   PubMed Web of Science ®Google Scholar
• Tilson M D. Carcinoid syndrome. Surg Clin North Am 1974; 54: 409–23
   PubMed Web of Science ®Google Scholar
• Moertel C G. An Odyssey in the land of small tumors. J Clin Oncol 1987; 5: 1503–22
   Web of Science ®Google Scholar
• Moertel C G, Sauer W G, Dockerty M B, Baggenstoss A H. Life history of the carcinoid tumor of the small intestine. Cancer 1961; 14: 901–12
   PubMed Web of Science ®Google Scholar
• Dawes L, Schulte W J, Condon R E. Carcinoid tumors. Arch Surg 1984; 119: 375–8
   PubMedGoogle Scholar
• Warner T F, O'Reilly G, Power L H. Carcinoid diathesis of the ileum. Cancer 1979; 43: 1900–5
   PubMed Web of Science ®Google Scholar
• Thompson G B, van Heerden J A, Kirk Martin J, Jr, Schutt A J, Ilstrup D M, Aidan Carney J. Carcinoid tumors of the gastrointestinal tract: presentation, management, and prognosis. Surgery 1985; 98: 1054–62
   PubMed Web of Science ®Google Scholar
• Strodel W E, Talpos G, Ecklhauser F, Thompson N. Surgical therapy for small-bowel carcinoid tumors. Arch Surg 1983; 118: 391–7
   PubMedGoogle Scholar
• Søreide O, Berstad T, Bakka A, et al. Surgical treatment as a principle in patients with advanced abdominal carcinoid tumors. Surgery 1991, In press
   Web of Science ®Google Scholar
• Sander R J, Axtell H K. Carcinoids of the gastrointestinal tract. Surg Gynecol Obstet 1964; 17: 369–80
   Google Scholar
• Thorson A, Bjørk G, Bjørkman G, Waldenstrøm J. Malignant carcinoid of the small intestine with metastases to the liver, valvular disease of the right side of the heart (pulmonary stenosis and tricuspid regurgitation without septal defect), peripheral vasomotor symptoms, bronchoconstriction and an unusual type of cyanosis. Am Heart J 1954; 47: 795–817
   PubMed Web of Science ®Google Scholar
• Pernow B, Waldenström J. Paroxysmal flushing and other symptoms caused by 5-hydroxytryplamine and histamine in patients with malignant tumors. Lancet 1954; 2: 951
   Web of Science ®Google Scholar
• Feldman J M, Scott Jones R. Carcinoid syndrome from gastrointestinal carcinoids without liver metastasis. Ann Surg 1982; 196: 33–7
   PubMed Web of Science ®Google Scholar
• Davis Z, Moertel C G, McIllrath D C. The malignant carcinoid syndrome. Surg Gynecol Obstet 1973; 137: 637–44
   PubMedGoogle Scholar
• MacGillivary D C, Synder D A, Druckner W, ReMine S G. Carcinoid tumors: the relationship between clinical presentation and extent of disease. Surgery 1991; 110: 68–72
   PubMed Web of Science ®Google Scholar
• Maton P N. The carcinoid syndrome [grand rounds at the National Institutes of Health]. JAMA 1988; 260: 1602–5
   PubMed Web of Science ®Google Scholar
• Stockmann F, Crcutzfeldt W. Approach to hepatic involvement by endocrine tumors of the gastrointestinal tract. Semin Liver Dis 1988; 8: 254–62
   PubMed Web of Science ®Google Scholar
• Hodgson H JF, Maton P N. Carcinoid and neuroendocrine tumours of the liver. Bailliere's Clin Gastroenterol 1987; 1: 35–61
   PubMedGoogle Scholar
• Creutzfeldt W, Stockmann F. Carcinoids and the carcinoid syndrome. Am J Med 1987; 82: 4–16, Suppl 5B
   PubMed Web of Science ®Google Scholar
• Oates J A. The carcinoid syndrome [editorial]. N Engl J Med 1986; 315: 702–3
   PubMed Web of Science ®Google Scholar
• Dery R. Theoretical and clinical considerations in anaesthesia for secreting carcinoid tumours. Can Anest Soc J 1971; 18: 245–63
   PubMedGoogle Scholar
• Mason R A, Steane P A. Carcinoid syndrome: its relevance to the anesthetist. Anesthesia 1976; 31: 228–42
   PubMed Web of Science ®Google Scholar
• March H M, Kirk Martin J, Kvols L K, et al. Carcinoid crisis during anesthesia: successful treatment with a somatostatin analogue. Anesthesiology 1987; 66: 89–91
   PubMed Web of Science ®Google Scholar
• Roy R C, Carter R F, Wright P D. Somatostatin, anaesthesia, and the carcinoid synchrome. Anaesthesia 1987; 42: 627–32
   PubMed Web of Science ®Google Scholar
• Foster J H, Berman M M. Solid liver tumors. Major problems in surgery. WB Saunders Co, Philadelphia 1977; 236–43
   Google Scholar
• Öberg K, Norheim I, Lind E, et al. Treatment of malignant carcinoid tumours with human leucocyte interferon: long-term results. Cancer Treat Rep 1986; 70: 1297–1304
   PubMedGoogle Scholar
• Kvols L K, Moertel C G, O'Connell M J, Schutt A J, Rubin J, Hahn R G. Treatment of the malignant carcinoid syndrome: evaluation of a long-acting somatostatin analogue. N Engl J Med 1986; 315: 663–6
   PubMed Web of Science ®Google Scholar
• Norheim I, Öberg K, Theodorsson-Norheim E, et al. Malignant carcinoid tumours. An analysis of 103 patients with regard to tumor localization, hormone production and survival. Ann Surg 1987; 206: 115–25
   PubMed Web of Science ®Google Scholar
• Makridis C, Öberg K, Juhlin C, et al. Surgical treatment of midgut carcinoid tumors. World J Surg 1990; 14: 377–85
   PubMed Web of Science ®Google Scholar
• Thorson A. Studies on carcinoid disease. Acta Med Scand 1958; 7–132, Suppl 334
   PubMedGoogle Scholar
• Grahame-Smith D G. Natural history and diagnosis of the carcinoid syndrome. Clin Gastroenterol 1974; 3: 575–94
   Google Scholar
• Sjöblom S M. Clinical presentation and prognosis of gastrointestinal carcinoid tumours. Scand J Gastroenterol 1988; 23: 779–87
   PubMed Web of Science ®Google Scholar
• Eckhauser F E, Argenta L C, Strodel W E, et al. Mesenteric angiopathy, intestinal gangrene, and mid-gut carcinoids. Surgery 1981; 90: 720–7
   PubMed Web of Science ®Google Scholar
• Pollack A V. Relief of flushing after resection of a secreting argentaffinoma. Br J Surg 1959; 46: 453–54
   Web of Science ®Google Scholar
• Wilson H, Butterick O D, Jr. Massive liver resection for control of severe vasomotor reactions secondary to malignant carcinoid. Ann Surg 1959; 149: 641–7
   PubMed Web of Science ®Google Scholar
• Mosenthal W T. Resection of massive liver metastases in the malignant carcinoid syndrome. Review and report of a case. Surg Clin North Am 1963; 43: 1253–62
   PubMed Web of Science ®Google Scholar
• Shorb P E, Jr, McCune W S. Carcinoid tumors of the gastrointestinal tract. An analysis of seventy cases. Am J Surg 1964; 107: 329–36
   PubMed Web of Science ®Google Scholar
• Chandler J J, Foster J H. Malignant carcinoid syndrome treated by resection of hepatic metastases. Am J Surg 1965; 109: 221–2
   PubMed Web of Science ®Google Scholar
• Buchanan K D, Johnston C F, O'Hare M MT, et al. Neuroendocrine tumors. A European view. Am J Med 1986; 81: 14–20, Suppl 6B
   PubMed Web of Science ®Google Scholar
• Ekberg H, Tranberg K-G, Andersson R, Jeppson B, Bengmark S. Major liver resection: perioperative course and management. Surgery 1986; 100: 1–8
   PubMed Web of Science ®Google Scholar
• Cobourn C S, Makowka L, Langer B, Taylor B R, Falk R E. Examination of patient selection and outcome for hepatic resection for metastatic disease. Surg Gynecol Obstet 1987; 165: 239–46
   PubMedGoogle Scholar
• Morrow C E, Grage T B, Sutherland D ER, Najarian J S. Hepatic resection for secondary neoplasms. Surgery 1982; 92: 610–3
   PubMed Web of Science ®Google Scholar
• Sugerbaker P H, Kemeny N. Management of metastatic cancer to the liver. Adv Surg 1989; 22: 1–56
   PubMedGoogle Scholar
• Martin J, Moertel C GF, Adson M A, Scutt A J. Surgical treatment of functioning metastatic carcinoid tumors. Arch Surg 1983; 118: 537–42
   PubMedGoogle Scholar
• Breedis C, Young G. The blood supply of neoplasms in the liver. Am J Pathol 1954; 30: 969–77
   PubMed Web of Science ®Google Scholar
• Ackerman N B, Lien W M, Kondi E S, Silverman N. The blood supply of experimental liver metastases. I. The distribution of hepatic artery and portal vein blood to ‘small’ and large tumors. Surgery 1969; 66: 1067–72
   PubMed Web of Science ®Google Scholar
• Aune S, Schistad G. Carcinoid liver metastases treated with hepatic dearterialization. Am J Surg 1972; 123: 715–7
   PubMed Web of Science ®Google Scholar
• McDermott W V, Hensle T W. Metastatic carcinoid to the liver treated by hepatic dearterialization. Ann Surg 1974; 180: 305–8
   PubMed Web of Science ®Google Scholar
• Bengmark S, Fredlund P, Hafström L O, Vang J. Present experience with hepatic dearterialization in liver neoplasms. Prog Surg 1974; 13: 141–66
   PubMedGoogle Scholar
• Sjöblom S M, Höckerstedt K, Järvinen H. Hepatic dearterialization in the treatment of carcinoid syndrome. Acta Chir Scand 1987; 153: 523–9
   PubMedGoogle Scholar
• Bengmark S, Ericsson M, Lunderquist A, Mårtensson H, Nobin A, Sako M. Temporary liver dearterialization in patients with metastatic carcinoid disease. World J Surg 1982; 6: 46–53
   PubMed Web of Science ®Google Scholar
• Blumgart L H, Allison D J. Resection and embolization in the management of secondary hepatic tumors. World J Surg 1982; 6: 32–45
   PubMed Web of Science ®Google Scholar
• Motan P N, Camilleri M, Griffin G, Allison D J, Hodgson H JF, Chadwick V S. Role of hepatic arterial embolisation in the carcinoid syndrome. Br Med J 1983; 287: 932–5
   PubMedGoogle Scholar
• Mitty H A, Warner R RP, Newman L H, Train J S, Paranes I H. Control of carcinoid syndrome with hepatic artery embolization. Radiology 1985; 155: 623–6
   PubMed Web of Science ®Google Scholar
• Mårtensson H, Nobin A, Bengmark S, Lunderquist A, Owman T, Sanden G. Embolization of the liver in the management of metastatic carcinoid tumors. J Surg Oncol 1984; 27: 152–8
   PubMed Web of Science ®Google Scholar
• Clouse M E, Lee R GL, Duszlak E J, Lokich J J, Alday M T. Hepatic artery embolization for metastatic endocrine-secreting tumors of the pancreas. Gastroenterology 1983; 85: 1183–6
   PubMed Web of Science ®Google Scholar
• Hanssen L E, Schrumpf E, Kolbenstvedt A N, Tausjø J, Dolva Lø. Treatment of malignant metastatic midgut carcinoid tumours with recombinant α2b interferon with or without prior hepatic artery embolization. Scand J Gastroenterol 1989; 24: 787–95
   PubMed Web of Science ®Google Scholar
• Makowka L, Tzakis A G, Mazzaferro V V, et al. Transplantation of the liver for metastatic endocrine tumors of the intestine and pancreas. Surg Gynecol Obstet 1989; 168: 107–11
   PubMedGoogle Scholar
• Arnold J C, O'Grady J G, Bird G L, Calne R Y, Williams R. Liver transplantation for primary and secondary hepatic apudomas. Br J Surg 1989; 76: 248–9
   PubMed Web of Science ®Google Scholar
• Zeitels J, Naunheim K, Kaplan E L, Strausse F, II. Carcinoid tumors. A 37-year experience. Arch Surg 1982; 117: 732–6
   PubMedGoogle Scholar
• Johnson L A, Lavin P, Moertel C G, et al. Carcinoids: the association of histologic growth pattern and survival. Cancer 1983; 51: 882–9
   PubMed Web of Science ®Google Scholar